Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Shares Outstanding (Diluted) (2019 - 2026)

Updated

Alnylam Pharmaceuticals (ALNY) recorded Shares Outstanding (Diluted) of 138.28 million in Q2 2026, up 5.9% from 130.63 million a year earlier and unchanged from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends

For FY2025, Alnylam Pharmaceuticals reported Shares Outstanding (Diluted) of 134.68 million, up 5.5% from FY2024.

  • Annual Shares Outstanding (Diluted) has increased for six straight years, with a five-year compound annual growth rate of 3.2% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Diluted) came in at 127.65 million in FY2024 (+2.2%), 124.91 million in FY2023 (+2.6%), 121.69 million in FY2022 (+2.7%) and 118.45 million in FY2021 (+3.0%).
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2019.
  • On a year-over-year basis, Shares Outstanding (Diluted) has increased for seven consecutive quarters, with growth averaging 3.8% over the last eight quarters.
  • Peak year-over-year performance for Shares Outstanding (Diluted) in the last five years was growth of 7.5% in Q3 2023, against a decline of 2.1% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at 138.23 million (Q1 2026), 134.68 million (Q4 2025) and 137.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 2.44 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 1.77 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 1.56 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 1.24 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 255.20 Mn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 138.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 138.28 Mn
Mar 31, 2026 138.23 Mn
Dec 31, 2025 134.68 Mn
Sep 30, 2025 137.35 Mn
Jun 30, 2025 130.63 Mn
Mar 31, 2025 129.68 Mn
Dec 31, 2024 127.65 Mn
Sep 30, 2024 128.59 Mn
Jun 30, 2024 126.73 Mn
Mar 31, 2024 126.14 Mn
Dec 31, 2023 124.91 Mn
Sep 30, 2023 131.34 Mn
Jun 30, 2023 124.66 Mn
Mar 31, 2023 124.11 Mn
Dec 31, 2022 121.69 Mn
Sep 30, 2022 122.17 Mn
Jun 30, 2022 120.90 Mn
Mar 31, 2022 120.39 Mn
Dec 31, 2021 118.45 Mn
Sep 30, 2021 119.14 Mn
API Access

Alnylam Pharmaceuticals Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ALNY&period=max&api_key=YOUR_API_KEY